# Healthcare AI Agent Ideas

## Tier 1 — Highest Impact, Clearest White Space

### A. Post-Discharge Care Coordination Agent
- **Problem:** 79% of readmissions are preventable; CMS penalized 3,043 hospitals $320M in FY2023; 20% of patients experience adverse events within 3 weeks of discharge (75% preventable)
- **What it does:** Calls patients post-discharge, checks symptoms, reconciles medications, schedules follow-ups, escalates red flags to care team
- **Why agents (not bots):** Multi-step coordination across patient, pharmacy, PCP, and specialist — requires reasoning, not just reminders
- **Monetization:** SaaS per-bed or per-discharge; tie pricing to readmission reduction outcomes
- **Buyer:** Hospital systems (CFO-level ROI story via HRRP penalty avoidance)

### B. Behavioral Health Triage & Navigation Agent
- **Problem:** 150M+ Americans live in mental health professional shortage areas; 25-day average psychiatry wait time; 57% of adults with mental illness receive no treatment
- **What it does:** Intake assessment, crisis routing, provider matching, appointment scheduling, between-session check-ins
- **Why now:** Mental health parity laws expanding coverage; post-COVID demand surge; Eleos raised $60M (market forming, not closed)
- **Monetization:** Per-member-per-month for health plans; per-organization for behavioral health groups
- **Buyer:** Health plans, behavioral health group practices

### C. Clinical Trial Matching & Enrollment Agent
- **Problem:** 85% of cancer trials fail to meet enrollment targets; avg. trial runs 6–7 months behind schedule; each month of delay costs pharma ~$37M; patients rarely know trials exist
- **What it does:** Ingests EHR data, matches against open trials, proactively reaches out to eligible patients, coordinates consent and scheduling
- **Why agents:** Full enrollment workflow (matching → outreach → consent → scheduling) is too complex for a simple rule engine
- **Monetization:** Per-enrollment fee to pharma/CROs; SaaS to health systems
- **Buyer:** Pharma clinical ops teams, CROs, academic medical centers

---

## Tier 2 — High Impact, Needs Differentiation

### D. Specialty-Specific Documentation + Workflow Agent
- **Specialties:** Oncology, Orthopedics, Cardiology
- **Problem:** Generic ambient scribes (Abridge, Nabla) miss specialty-specific terminology, order sets, and workflow steps
- **What it does:** Specialty-trained documentation + order entry + referral coordination + payer-specific coverage checking
- **Why now:** Abridge/Nabla are horizontal tools; deep verticals remain wide open
- **Monetization:** Premium SaaS per-clinician to specialty practices
- **Buyer:** Specialty group practices and health system specialty departments

### E. Chronic Disease Management Agent
- **Conditions:** Diabetes, Heart Failure, Hypertension
- **Problem:** ~50% medication adherence rates globally; uncontrolled chronic disease drives the majority of preventable hospitalizations
- **What it does:** Daily check-ins, symptom monitoring, medication reminders, lifestyle coaching, care escalation routing
- **Why now:** CMS value-based care programs reward outcomes; Hippocratic AI is early-stage and not dominant
- **Monetization:** Per-member-per-month to health plans or ACOs
- **Buyer:** Health plans, accountable care organizations (ACOs)

### F. Medication Reconciliation Agent (Transitions of Care)
- **Problem:** $38–50B/year from medication errors; 91% are prescribing errors; transitions of care (hospital → home, hospital → SNF) are the highest-risk moments
- **What it does:** Cross-references discharge meds vs. home meds vs. pharmacy fill history; flags discrepancies; coordinates resolution with patient, prescriber, and pharmacy
- **Monetization:** SaaS per-bed to hospitals; risk-sharing arrangements with health plans
- **Buyer:** Hospital systems, skilled nursing facilities

---

## Market Context

### What's Already Saturated (avoid without major differentiation)
| Problem | Dominant Player | Raised/Status |
|---|---|---|
| Ambient documentation | Abridge | $750M, $5.3B valuation, 200+ health systems |
| Prior authorization | Cohere Health | $200M raised, 12M PA requests/year |
| Revenue cycle / denial prevention | Waystar | Public company, $1.25B acquisition |
| Patient-facing clinical AI | Hippocratic AI | $404M raised, 50+ health systems |

### Who Buys Healthcare AI (2025)
| Buyer | Annual AI Spend | Priorities |
|---|---|---|
| Hospital Systems | $1.0B (75%) | Readmissions, revenue cycle, burnout |
| Outpatient Providers | $280M | Prior auth, scheduling, documentation |
| Health Plans/Payers | $50M (slow buyers, 11-month sales cycles) | Prior auth, claims processing |
| Pharma/Life Sciences | <$50M | Clinical trials, R&D |

---

## Key Constraints for Any Healthcare Agent

1. **HIPAA** — Any agent handling PHI requires a Business Associate Agreement (BAA) with partners
2. **FDA regulation** — Clinical decision support that makes specific diagnosis/treatment recommendations requires 510(k) clearance
3. **EHR integration** — Epic holds 35%+ market share; FHIR R4 APIs are the standard integration path; Epic App Orchard for distribution
4. **Clinician trust** — Must support human-in-the-loop review; surface confidence levels; maintain full audit trails
5. **Liability** — Agents need clearly defined scope-of-practice limits and escalation protocols

---

## Validation Next Steps

Before building, validate with:
- 5–10 hospital discharge planners / care coordinators (post-discharge agent)
- 3–5 behavioral health group practice managers (triage agent)
- 2–3 pharma clinical ops leaders (trial matching agent)
- Epic App Orchard requirements for integration feasibility
- CMS HRRP payment structures to quantify hospital ROI

---

*Research sources: AMA, AHA, AHRQ PSNet, McKinsey, Deloitte, FierceHealthcare, JAMIA, CMS, Crunchbase, MarketsandMarkets (2024–2026)*
